Alejandra Carvajal insider trades

Open-market stock purchases and sales by Alejandra Carvajal, Chief Legal Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Dec 1, 2015.

Recent trades

DateStockTradeValue
Aug 3, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Aug 3, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$48.8K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$107K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$1.9M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$283K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$231K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$746K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$81.4K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$598K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: other filings, last Aug 3, 2026
  • MRSN Mersana Therapeutics, Inc: 9 sales, last Jan 6, 2026
  • MNTA Momenta Pharmaceuticals Inc: 14 sales, last Oct 1, 2020
  • CERU Cerulean Pharma Inc: other filings, last Jan 5, 2017

Get free alerts when Alejandra Carvajal files a new trade →